ZA985896B - Cyclic azapeptides - Google Patents

Cyclic azapeptides

Info

Publication number
ZA985896B
ZA985896B ZA985896A ZA985896A ZA985896B ZA 985896 B ZA985896 B ZA 985896B ZA 985896 A ZA985896 A ZA 985896A ZA 985896 A ZA985896 A ZA 985896A ZA 985896 B ZA985896 B ZA 985896B
Authority
ZA
South Africa
Prior art keywords
azapeptides
cyclic
cyclic azapeptides
Prior art date
Application number
ZA985896A
Other languages
English (en)
Inventor
Alfred Jonczyk
Simon Goodman
Horst Kessler
Jochen Wermuth
Jorg Schmitt
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ZA985896B publication Critical patent/ZA985896B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ZA985896A 1997-07-04 1998-07-03 Cyclic azapeptides ZA985896B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19728524A DE19728524A1 (de) 1997-07-04 1997-07-04 Cyclische Azapeptide

Publications (1)

Publication Number Publication Date
ZA985896B true ZA985896B (en) 1999-06-14

Family

ID=7834596

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA985896A ZA985896B (en) 1997-07-04 1998-07-03 Cyclic azapeptides

Country Status (20)

Country Link
US (1) US6534478B1 (xx)
EP (1) EP1001979B1 (xx)
JP (1) JP2002511872A (xx)
KR (1) KR20010014267A (xx)
CN (1) CN1261895A (xx)
AR (1) AR010924A1 (xx)
AT (1) ATE297947T1 (xx)
AU (1) AU733831B2 (xx)
BR (1) BR9810394A (xx)
CA (1) CA2297181A1 (xx)
DE (2) DE19728524A1 (xx)
HU (1) HUP0003357A3 (xx)
ID (1) ID23415A (xx)
NO (1) NO20000016L (xx)
PL (1) PL337616A1 (xx)
RU (1) RU2188205C2 (xx)
SK (1) SK173599A3 (xx)
TW (1) TW482768B (xx)
WO (1) WO1999001472A1 (xx)
ZA (1) ZA985896B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA71608C2 (en) * 1999-03-11 2004-12-15 Merck Patent Gmbh A method for producing the cyclic pentapeptide
US6723722B1 (en) 1999-06-22 2004-04-20 Takeda Chemical Industries, Ltd. Acylhydrazine derivatives, their production and use
GB0217017D0 (en) * 2002-07-23 2002-08-28 Bioacta Ltd Peptide 2
WO2008033557A2 (en) * 2006-09-15 2008-03-20 Siemens Medical Solutions Usa, Inc. Click chemistry-derived cyclic peptidomimetics as integrin markers
EP2182974B1 (en) 2007-07-27 2015-08-26 Siemens Medical Solutions USA, Inc. Cyclic azapeptides as integrin markers
US8133472B2 (en) 2008-04-30 2012-03-13 Siemens Medical Solutions Usa, Inc. Cyclopeptides containing RGD mimetics as imaging markers for integrins
WO2009148554A1 (en) 2008-05-30 2009-12-10 Siemens Medical Solutions Usa, Inc. Achievement of high therapeutic index through molecular imaging guided targeted drug treatment
CA2665302A1 (en) * 2009-05-01 2010-11-01 Universite De Montreal Cd36 modulation and uses thereof
CN101906144B (zh) * 2009-06-03 2013-06-19 首都医科大学 一根Arg-Gly-Asp-Val链通过Asp与两根脂肪醇链的偶联物、它们的合成及在医学中的应用
KR101335203B1 (ko) * 2010-03-26 2013-11-29 숙명여자대학교산학협력단 혈관신생촉진용 펩타이드 및 이의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3398747B2 (ja) * 1992-06-04 2003-04-21 メレルダウファーマスーティカルズ インコーポレイテッド 抗血小板剤としての立体配位が制限されたペプチド類似体
UA43823C2 (uk) * 1992-07-06 2002-01-15 Мерк Патент Геселлшафт Міт Бесшренктер Хафтунг ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ДЛЯ ІНГІБУВАННЯ ІНТЕГРИН <font face="Symbol">a</font><sub>V</sub><font face="Symbol">b</font><sub>3</sub>-ОПОСЕРЕДКОВАНОЇ КЛІТИННОЇ АДГЕЗІЇ КЛІТИН ССАВЦІВ, СПОСІБ ЛІКУВАННЯ ТА ПРОФІЛАКТИКИ ЗАХВОРЮВАННЯ, АСОЦІЙОВАНОГО З ПОРУШЕННЯМ АДГЕЗІЇ КЛІТИН, СПОСІБ БЛОКУВАННЯ ЗВ'ЯЗУВАННЯ ФІБРИНОГЕНОМ ІНТЕГРИНУ, КОМПОЗИЦІЯ ДЛЯ ЗАГОЄННЯ РАН
WO1995023811A1 (en) * 1994-03-04 1995-09-08 The Du Pont Merck Pharmaceutical Company Novel carbocyclic compounds which inhibit platelet aggregation by interaction with the gpiib/iiia receptor complex
US5858972A (en) * 1996-01-11 1999-01-12 La Jolla Cancer Research Foundation Antithrombotic agents and methods of use
ZA978758B (en) * 1996-10-02 1999-03-30 Du Pont Merck Pharma Technetium-99m-labeled chelator incorporated cyclic peptides that bind to the GPIIb/IIIa receptor as imaging agents
DE19653036A1 (de) * 1996-12-19 1998-06-25 Merck Patent Gmbh Cyclopeptidderivate

Also Published As

Publication number Publication date
HUP0003357A3 (en) 2001-12-28
AU8541198A (en) 1999-01-25
KR20010014267A (ko) 2001-02-26
BR9810394A (pt) 2000-09-05
EP1001979B1 (de) 2005-06-15
NO20000016D0 (no) 2000-01-03
AU733831B2 (en) 2001-05-24
ATE297947T1 (de) 2005-07-15
JP2002511872A (ja) 2002-04-16
DE59812870D1 (de) 2005-07-21
DE19728524A1 (de) 1999-01-07
AR010924A1 (es) 2000-07-12
CN1261895A (zh) 2000-08-02
SK173599A3 (en) 2000-06-12
ID23415A (id) 2000-04-20
US6534478B1 (en) 2003-03-18
TW482768B (en) 2002-04-11
PL337616A1 (en) 2000-08-28
CA2297181A1 (en) 1999-01-14
HUP0003357A2 (hu) 2001-02-28
RU2188205C2 (ru) 2002-08-27
EP1001979A1 (de) 2000-05-24
WO1999001472A1 (de) 1999-01-14
NO20000016L (no) 2000-01-03

Similar Documents

Publication Publication Date Title
TW373796U (en) Keystoke structure
DE69840493D1 (en) Tionseinlage
HK1015969A1 (en) 1-poliges kontaktsystem
GB9715267D0 (en) Stethescope structure
ZA985896B (en) Cyclic azapeptides
GB9707849D0 (en) Structure
GB2330642B (en) mounting
GB9709717D0 (en) Case
PL338125A1 (en) Cartridge-projectile
GB2324019B (en) Lawn-Trimmer
HU9700115V0 (en) Case
TW334796U (en) Improved Hula-hoop structure
TW334786U (en) Improved bathbrush structure
TW333808U (en) Improved jardiniere structure
GB9709555D0 (en) Encapsulation
GB9701325D0 (en) Sequence
GB9700871D0 (en) Sequence
GB9700730D0 (en) Sequence
TW331908U (en) Improved undervalve
GB9827955D0 (en) Improved weatherbar
GB9726744D0 (en) Improved weatherbar
TW328856U (en) Attached terminals
TW334678U (en) Dovecote structure
TW446065U (en) Door-in-door structure
HU9700108V0 (en) Structure